- Home
- FBIOP vs WDAY Comparison
FBIOP vs WDAY Comparison
Compare FBIOP & WDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- WDAY
- Stock Information
- Founded
- FBIOP N/A
- WDAY 2005
- Country
- FBIOP United States
- WDAY United States
- Employees
- FBIOP 101
- WDAY N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- WDAY EDP Services
- Sector
- FBIOP Health Care
- WDAY Technology
- Exchange
- FBIOP Nasdaq
- WDAY Nasdaq
- Market Cap
- FBIOP N/A
- WDAY N/A
- IPO Year
- FBIOP N/A
- WDAY 2012
- Fundamental
- Price
- FBIOP $8.41
- WDAY $224.86
- Analyst Decision
- FBIOP
- WDAY Buy
- Analyst Count
- FBIOP 0
- WDAY 27
- Target Price
- FBIOP N/A
- WDAY $301.08
- AVG Volume (30 Days)
- FBIOP N/A
- WDAY 2.3M
- Earning Date
- FBIOP N/A
- WDAY 08-21-2025
- Dividend Yield
- FBIOP N/A
- WDAY N/A
- EPS Growth
- FBIOP N/A
- WDAY N/A
- EPS
- FBIOP N/A
- WDAY 1.81
- Revenue
- FBIOP N/A
- WDAY $8,696,000,000.00
- Revenue This Year
- FBIOP N/A
- WDAY $14.87
- Revenue Next Year
- FBIOP N/A
- WDAY $13.03
- P/E Ratio
- FBIOP N/A
- WDAY $123.25
- Revenue Growth
- FBIOP N/A
- WDAY 14.95
- 52 Week Low
- FBIOP N/A
- WDAY $199.81
- 52 Week High
- FBIOP N/A
- WDAY $294.00
- Technical
- Relative Strength Index (RSI)
- FBIOP 56.06
- WDAY 30.20
- Support Level
- FBIOP $7.82
- WDAY $237.10
- Resistance Level
- FBIOP $8.60
- WDAY $242.78
- Average True Range (ATR)
- FBIOP 0.45
- WDAY 4.88
- MACD
- FBIOP -0.01
- WDAY -0.83
- Stochastic Oscillator
- FBIOP 80.73
- WDAY 1.62
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.